Yposkesi launches LentiSure™, Lentiviral (LV) Vector production platform optimized for higher yields
Galapagos and NovAliX enter into an integrated drug discovery collaboration
Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow-up
Nosopharm selected for French Tech Health20 program
BioWin – Visibility and market recognition for launch of recruitment initiative
Launch of recruitment initiative
Labor Dr. Brunner adopts QuantaMatrix dRAST solution in routine clinical use
Novartis choisit Banook Group pour faciliter le parcours patient, associé à la prise en charge d’un de ses traitements en oncologie
Carthera announces positive outcome of End-of-Phase 2 meeting with FDA for SonoCloud-9 system for treatment of recurrent glioblastoma
